WILLIAM J. CHASE - Director at Intellia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
NTLA on Nasdaq
All Insider Reports
All Insider Reports

WILLIAM J. CHASE - trading volume in the past year for Intellia Therapeutics, Inc.

Holdings reported by WILLIAM J. CHASE for Intellia Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 134,693 $1,350,970 $10.03 20 Aug 2025 Direct
Stock Option (right to buy) 11,450 11 Jun 2025 Direct Common Stock

Transactions reported by WILLIAM J. CHASE for Intellia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.